Status:
UNKNOWN
Diffusion-Weighted Magnetic Resonance Imaging
Lead Sponsor:
Samsung Medical Center
Conditions:
Hepatocellular Carcinoma
Spine Metastasis
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
Recently, diffusion-weighted (DW) MR imaging has widened its application on various oncologic applications. Especially, it is expected the DW MRI could provide valuable information about early respons...
Eligibility Criteria
Inclusion
- Hepatocellular carcinoma
- Spine metastasis
- Eastern Cooperative Oncology Group (ECOG) performance status 0 to 3
- 20 or older age
- informed consent
- consent to birth control during 6 months after treatment
Exclusion
- less than 12 weeks of expected survival
- indication of emergency operation
- uncontrolled ascites or encephalopathy
- previous RT field lesion (within in 1 month)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02242786
Start Date
August 1 2014
Last Update
November 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710